→
Stock Comparison
Side-by-side fundamentals, valuation, and AI summaries for both tickers.
UNH
UNITEDHEALTH GROUP INC
UnitedHealth Group Inc has a market capitalization of $356.14B and a current price of $390.93, reflecting a decrease of 2.02% from the previous close of $399. The company has a P/E ratio of 29.55 and reported a revenue growth of 11.81% year-over-year, while its EPS has declined by 14.70% year-over-year.
Investors may consider the mixed signals in UnitedHealth's financial performance as they evaluate their positions.
JNJ
Johnson & Johnson
Johnson & Johnson has a market capitalization of $654.02B and a current stock price of $269.21, reflecting a slight increase of 0.02% today. The company's P/E ratio stands at 24.41, while its P/S ratio is 6.94, indicating strong earnings relative to its stock price. Year-over-year EPS growth is reported at 90.50%, alongside a revenue growth of 6.05%. The current ratio is 1.03, and the debt-to-equity ratio is 0.48, suggesting a stable financial position.
Investors should consider the various financial metrics and market conditions when evaluating Johnson & Johnson's stock performance.
UNH
Bull Case
Some investors point to UnitedHealth's 11.81% revenue growth year-over-year as a sign of strong operational performance. Additionally, the stock has appreciated by 39.4% over the last six months, indicating positive market sentiment.
Bear Case
Conversely, the company's EPS growth has declined by 14.70% year-over-year, raising concerns about its profitability. The recent drop of 2.02% in stock price may reflect investor apprehension following reports of changes in their Florida WellMed clinics.
JNJ
Bull Case
Some investors highlight Johnson & Johnson's impressive EPS growth of 90.50% year-over-year, indicating strong profitability. Additionally, the company's revenue growth of 6.05% suggests a steady demand for its products in the pharmaceutical preparations industry.
Bear Case
Conversely, concerns over Johnson & Johnson's performance relative to the broader market have been raised, with reports indicating a more significant dip than its peers. The P/E ratio of 24.41 may also suggest that the stock is priced at a premium compared to its earnings potential.
UNITEDHEALTH GROUP INC: UnitedHealth Group Inc has a market capitalization of $356.14B and a current price of $390.93, reflecting a decrease of 2.02% from the previous close of $399. The company has a P/E ratio of 29.55 and reported a revenue growth of 11.81% year-over-year, while its EPS has declined by 14.70% year-over-year. Johnson & Johnson: Johnson & Johnson has a market capitalization of $654.02B and a current stock price of $269.21, reflecting a slight increase of 0.02% today. The company's P/E ratio stands at 24.41, while its P/S ratio is 6.94, indicating strong earnings relative to its stock price. Year-over-year EPS growth is reported at 90.50%, alongside a revenue growth of 6.05%. The current ratio is 1.03, and the debt-to-equity ratio is 0.48, suggesting a stable financial position.
UNITEDHEALTH GROUP INC: Some investors point to UnitedHealth's 11.81% revenue growth year-over-year as a sign of strong operational performance. Additionally, the stock has appreciated by 39.4% over the last six months, indicating positive market sentiment. Johnson & Johnson: Some investors highlight Johnson & Johnson's impressive EPS growth of 90.50% year-over-year, indicating strong profitability. Additionally, the company's revenue growth of 6.05% suggests a steady demand for its products in the pharmaceutical preparations industry.
UNITEDHEALTH GROUP INC risks: Conversely, the company's EPS growth has declined by 14.70% year-over-year, raising concerns about its profitability. The recent drop of 2.02% in stock price may reflect investor apprehension following reports of changes in their Florida WellMed clinics. Johnson & Johnson risks: Conversely, concerns over Johnson & Johnson's performance relative to the broader market have been raised, with reports indicating a more significant dip than its peers. The P/E ratio of 24.41 may also suggest that the stock is priced at a premium compared to its earnings potential.
AI-powered portfolio intelligence, daily briefs, and real-time monitoring for every stock you own.
Not financial advice. Informational use only. AI-generated content may contain errors. Consult a licensed financial advisor before making investment decisions.